Enzyme News and Research

RSS

Comparative genome analysis of fungi brings new knowledge to develop protein production

VTT's Research Scientist Mikko Arvas presents his doctoral thesis on 19 October at 12 at the University of Helsinki, Finland.

17 Oct 2007

Low-volume whole-blood sensors could transform cardiac testing

University of Ulster researchers have teamed up with scientists at the Indian Institute of Technology, Bombay on a project to develop low-volume whole-blood sensors that could transform point-of-care cardiac testing.

15 Oct 2007

The importance of the endocannabinoid-system

Cannabis (marijuana) is the most widely produced plant-based illicit drug worldwide and the illegal drug most frequently used in Europe.

15 Oct 2007

Enzyme TPPII may contribute to obesity

The enzyme TPPII may contribute to obesity by stimulating the formation of fat cells, suggests a study in EMBO reports this week.

15 Oct 2007

New research may show why some prostate cancer recurs after treatment

Cancer researchers have long worked to understand why some prostate cancers recur after the use of therapies designed to stop the production of testosterone and other androgens that fuel cancer cell growth.

12 Oct 2007

Research shows how stem cells decide to become either skeletal or smooth muscle

Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).

11 Oct 2007

New understanding of stem cell aging

The Stowers Institute's Xie Lab has published recent findings that reveal some of the factors underlying the aging of stem cells.

11 Oct 2007

Heart drug perindopril helps seniors get active

According to scientists from Dundee University in Scotland, when seniors were given a drug commonly prescribed for heart conditions they were able to do more exercise.

10 Oct 2007

$Accentia announces investigational new drug application for Revimmune for refractory MS$

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia Biopharmaceuticals has announced that it met with the Food and Drug Administration (FDA) on September 26, 2007 for a scheduled pre-Investigational New Drug (pre-IND) meeting on Revimmune.

10 Oct 2007

Perindopril for improving physical function in elderly people

A decline in physical function with age is strongly associated with disability in later life.

9 Oct 2007

One injection of gene therapy spreads through brain in animal study

By targeting a site in a mouse brain well connected to other areas, researchers successfully delivered a beneficial gene to the entire brain - after one injection of gene therapy.

9 Oct 2007

Gene may hold key to future cancer hope

Scientists may have discovered a new way of killing tumours in what they hope could one day lead to alternative forms of cancer treatments.

From The University of Manchester 9 Oct 2007

Potential new treatment for Huntington's disease found

MassGeneral Institute for Neurodegererative Disorders (MIND) researchers have identified a compound that may lead to a treatment that could protect against the effects of Huntington's Disease (HD).

9 Oct 2007

Fraunhofer pharmaceutical agent speeds drug development

It takes a great deal of time and money to develop a new drug. At Biotechnica in Hanover from October 9 to 11, the Fraunhofer Life Sciences Alliance will demonstrate how a pharmaceutical agent can make its way more quickly from the research laboratory to the pharmacy.

8 Oct 2007

Genzyme receives Japanese marketing approval for Elaprase

Genzyme Corp. has announced that it has received approval to market Elaprase (idursulfase) in Japan for the treatment of Hunter syndrome.

4 Oct 2007

New findings on cholesterol metabolism in the brain and Alzheimer's disease

Although the causes of Alzheimer's disease are not completely understood, amyloid-beta (A-beta) is widely considered a likely culprit - the "sticky" protein clumps into plaques thought to harm brain cells.

4 Oct 2007

Anorexia as addictive as ectasy

French scientists say that anorexia is comparable to the drug Ecstasy as both appear to activate some of the same brain pathways

4 Oct 2007

Linking two molecular pieces may offer new approaches to treating Alzheimer's disease

Researchers have uncovered a biological link between the protein whose mutation causes early-onset Alzheimer's disease (AD) and a gene variant linked to late-onset AD.

4 Oct 2007

Isis Pharmaceuticals awarded $1.5 million NIH grant to improve RNAi-based therapeutics

Isis Pharmaceuticals, Inc. has announced that it has been awarded a multi-year Phase 2 Small Business Innovation Research (SBIR) grant by the National Institutes of Health (NIH) for up to $1.5 million to design oligonucleotide drugs that can exploit the RNA interference (RNAi) antisense mechanism for disease treatment.

4 Oct 2007

Tiny micro-incubator to culture living cells for lab tests

Integrating silicon microchip technology with a network of tiny fluid channels, some thinner than a human hair, researchers at The Johns Hopkins University have developed a thumb-size micro-incubator to culture living cells for lab tests.

3 Oct 2007